Novartis Pharmaceuticals Corporation Diovan (valsartan) 160 mg Recall
Announced 2026-08-19 · FDA
Diovan (valsartan) 160 mg, 90 tablets (Rx only) is recalled due to failed dissolution specifications. Lot AV5913C with expiry 6/2027 is included in the recall, distributed nationwide in the United States, and the FDA is the agency involved.
| Brand | Novartis Pharmaceuticals Corporation |
|---|---|
| Product | Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 |
| Reason | Failed Dissolution Specifications |
| Severity | moderate |
| Distribution | US Nationwide |
| Agency | FDA |
WHAT YOU SHOULD DO
- Stop using Lot AV5913C Diovan 160 mg.
- Consult your healthcare provider or pharmacist for guidance and potential replacement.
- Return the recalled product to the place of purchase or follow recall instructions from the FDA.
How to identify the recalled item
| Lot / date codes | Lot AV5913C, Expiry: 6/2027 |
|---|---|
| Lot / date codes | Lot AV5913C, Expiry: 6/2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.